Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousLiver TransplantationBone Marrow TransplantationKidney TransplantationTransplantation ConditioningStem Cell TransplantationTreatment OutcomeHeart TransplantationGraft SurvivalMultiple MyelomaLung TransplantationCell TransplantationPeripheral Blood Stem Cell TransplantationCombined Modality TherapyMelphalanHematopoietic Stem Cell MobilizationOrgan TransplantationRecurrenceBlood Transfusion, AutologousGraft vs Host DiseaseGraft RejectionRetrospective StudiesTime FactorsLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsSalvage TherapyBone Marrow PurgingTransplantation ImmunologyWhole-Body IrradiationAntigens, CD34TransplantationSurvival AnalysisImmunosuppressive AgentsCyclophosphamideCarmustineRemission InductionFollow-Up StudiesDisease-Free SurvivalTransplantation ChimeraSurvival RateHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsBusulfanTransplantation, IsogeneicEtoposideHodgkin DiseaseLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationPrognosisCytarabineHeart-Lung TransplantationMyeloablative AgonistsProspective StudiesImmunosuppressionGraft vs Tumor EffectTransplantation ToleranceTissue and Organ ProcurementHistocompatibility TestingBone MarrowAntineoplastic AgentsPostoperative ComplicationsSkin TransplantationLiver FailureMesenchymal Stem Cell TransplantationFetal Tissue TransplantationCells, CulturedAntibodies, MonoclonalFeasibility StudiesLeukemiaThalidomideTransplantation, HeterologousVincristineTissue TransplantationBone Marrow CellsHematopoiesisLymphomaCell SeparationBlood Component RemovalLeukemia, Myeloid, AcuteDrug Therapy, CombinationFlow CytometryGenetic TherapyPrednisoneStem CellsKanamycin KinaseWaiting ListsHistocompatibilityDoxorubicinNeoplasm, ResidualCorneal TransplantationMyelodysplastic SyndromesCyclosporine